Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China flag China · Delayed Price · Currency is CNY
15.48
+0.24 (1.57%)
Oct 30, 2026, 3:04 PM CST

SHE:002603 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
701.741,105853.03940.511,904995.26
Trading Asset Securities
1,816764.42-205.97518.3855.27
Cash & Short-Term Investments
2,5181,869853.031,1462,4231,051
Cash Growth
29.48%119.14%-25.60%-52.68%130.61%-32.40%
Accounts Receivable
1,9281,6491,3902,5962,1782,361
Other Receivables
16.8916.09130.075.596.544.73
Receivables
1,9441,6651,5202,6022,1842,366
Inventory
1,4781,4891,7462,4592,0221,673
Prepaid Expenses
-4.6626.0993.90.739.39
Other Current Assets
126.94178.59189.28242.67624.8473.65
Total Current Assets
6,0675,2064,3356,5447,2545,602
Property, Plant & Equipment
6,6036,9477,2537,3116,2295,758
Long-Term Investments
2.455.576.51,6511,3491
Goodwill
98.6103.28109.51115.75--
Other Intangible Assets
917.44791.87802.57743.52724.01660.5
Long-Term Deferred Tax Assets
157.14218.35365.84183.58284.43117
Long-Term Deferred Charges
177.9260.12266.88189.37107.16239.33
Other Long-Term Assets
128.97142.72180.36241.39392.65527.03
Total Assets
14,15313,67513,31916,97916,34112,905

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
1,7861,4681,8972,8472,0611,621
Accrued Expenses
203.64336.31350.83419.64644.78269.71
Short-Term Debt
---600.35500.35702.48
Current Portion of Long-Term Debt
---201.12150.12-
Current Portion of Leases
7.799.698.245.55.8613.43
Current Income Taxes Payable
134.0636.8623.4642.45242.1511.38
Current Unearned Revenue
303.6305.76272.34287.521,106301.56
Other Current Liabilities
8.3851.3155.2643.58140.3540.7
Total Current Liabilities
2,4432,2082,6074,4474,8502,960
Long-Term Debt
---599.1200.15500.47
Long-Term Leases
13.2816.0418.2113.0114.9712.53
Long-Term Unearned Revenue
350.72359.75377.92352.37335.02357.84
Long-Term Deferred Tax Liabilities
103.82109.11114.25130.1410.241.39
Total Liabilities
2,9112,6933,1175,5415,4113,833

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,6711,6711,6711,6711,6711,671
Additional Paid-In Capital
-2,3242,3432,3432,3432,343
Retained Earnings
7,2637,0026,2177,4436,9265,065
Comprehensive Income & Other
2,315-7.83-7.12-6.61-7.22-9.71
Total Common Equity
11,24910,98910,22311,45010,9329,069
Minority Interest
-7.34-7.21-21.4-11.73-1.953.04
Shareholders' Equity
11,24210,98210,20211,43810,9309,072
Total Liabilities & Equity
14,15313,67513,31916,97916,34112,905

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
21.0725.7426.451,419871.451,229
Net Cash (Debt)
2,4971,844826.58-272.61,551-178.37
Net Cash Growth
30.43%123.04%----
Net Cash Per Share
1.491.100.49-0.160.93-0.11
Filing Date Shares Outstanding
1,6711,6711,6711,6711,6711,671
Total Common Shares Outstanding
1,6711,6711,6711,6711,6711,671
Working Capital
3,6242,9981,7282,0972,4042,642
Book Value Per Share
6.736.586.126.856.545.43
Tangible Book Value
10,23310,0949,31110,59010,2088,409
Tangible Book Value Per Share
6.136.045.576.346.115.03
Buildings
-5,9335,6685,4074,3533,620
Machinery
-3,8763,5813,0982,4842,005
Construction In Progress
-890.661,1971,4711,5741,950